pCODR Registration

Welcome. To submit and contribute drug review information, input, and/or feedback online, you must be registered with the pan-Canadian Oncology Drug Review (pCODR). You may be eligible to register if you are a:

• member of a patient advocacy group (or an individual patient or caregiver in cases where there is no patient advocacy group)
• clinician
• member of a tumour group
• representative of a drug manufacturer

Please review the following eligibility criteria before submitting an Online Registration form. If you have already registered, you may log in.

Eligibility Criteria

To register with pCODR, you must meet all the criteria in one of the following categories:

Patient Advocacy Group

1. You are a member of a patient advocacy or care group
   and
2. Your patient group:
   • has a mandate that pre-dates the decision to register with pCODR
   • has a means of contacting and communicating with its membership, and
   • represents patients or caregivers impacted by cancer

Note: Individual patients and caregivers who wish to submit input for a pCODR drug review should first contact us at [email protected] to confirm the absence of a relevant patient group.

Clinician

1. You are an actively practising oncologist or physician treating cancer patients, an oncology pharmacist,^a or an oncology nurse;^a and
2. You submit a declaration of conflict of interest.

^a Note: The input from an oncology pharmacist and oncology nurse must be part of a joint submission with a registered oncologist or a physician treating cancer.

Tumour Group

1. You are a clinician member of a tumour group
   and
2. The tumour group is affiliated with and recognized by a provincial cancer agency or one of the provincial or territorial Ministries of Health.

Drug Manufacturer

1. You are an employee or representative of a drug manufacturer
   and
2. The drug manufacturer:
   • produces and distributes drugs used for the active treatment of cancer
   • has previously submitted to Health Canada for market authorization purposes
     and
   • intends to submit a drug to us for pCODR review.

How to Register for the our Collaborative Workspaces - Pharmaceutical Reviews

Note: It is important to have your registration completed in advance of the Pharmaceutical Reviews deadlines for submitting information, input, and/or feedback.

When you log in as a user, you will be automatically directed to one of four pages based on your profile: drug manufacturer, tumour group, patient group, or clinician.

If you have any questions about the registration process, please send us an email at [email protected].